Stock Market Reviews

HCAT (Health Catalyst, Inc.) News

Get the latest news, insights, and market updates on HCAT (Health Catalyst, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• How The New Price Target Is Reframing Health Catalyst’s Story And Fair Value
  Health Catalyst is back in focus as the latest research update resets the stock's price target, signalling a shift in how the market is thinking about its future potential. With no previous target disclosed here, this new benchmark becomes a fresh reference point for investors trying to make sense of the evolving story. Stay tuned to see how you can keep on top of these changing targets and the broader narrative around Health Catalyst going forward. Stay updated as the Fair Value for Health...
  Jan 27, 2026 - $HCAT
• Health Catalyst, MongoDB, Asana, Domo, and RingCentral Stocks Trade Up, What You Need To Know
  A number of stocks jumped in the afternoon session after reports of easing geopolitical tensions in Greenland boosted investor sentiment.
  Jan 22, 2026 - $HCAT
• Q3 Earnings Highs And Lows: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks
  Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Health Catalyst (NASDAQ:HCAT) and the best and worst performers in the data analytics industry.
  Jan 19, 2026 - $HCAT
• As AI use in healthcare rises, Waystar is riding the wave
  Bank of America names Waystar as its top 2026 pick, betting AI will turn "too-cheap" growth into durable gains
  Jan 15, 2026 - $HCAT
• Health Catalyst, Veeva Systems, 8x8, Amplitude, and DocuSign Stocks Trade Down, What You Need To Know
  A number of stocks fell in the afternoon session after markets pulled back as reports surfaced that Chinese customs authorities blocked Nvidia's H200 AI chips, effectively halting their entry despite recent U.S. export approvals.
  Jan 14, 2026 - $HCAT
• 3 Russell 2000 Stocks Walking a Fine Line
  The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
  Jan 7, 2026 - $HCAT
• 3 Value Stocks We Find Risky
  Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
  Jan 6, 2026 - $HCAT
• 3 Stocks Under $10 We’re Skeptical Of
  Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
  Dec 31, 2025 - $HCAT
• 3 Software Stocks Walking a Fine Line
  Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with high valuation multiples that make fundraising easier, but they have capped returns lately as the industry was flat over the past six months and trailed the S&P 500’s 13.3% gain.
  Dec 25, 2025 - $HCAT
• Health Catalyst Insider Ups Holding By 109% During Year
  Looking at Health Catalyst, Inc.'s ( NASDAQ:HCAT ) insider transactions over the last year, we can see that insiders...
  Dec 24, 2025 - $HCAT